atherogenesis, and thrombosis, and therefore endothelial dysfunction could, in part, contribute to cardiovascular morbidity and mortality associated with PM 2.5 exposure. However, previous data showing associations between ambient PM 2.5 and endothelial dysfunction 18, 19 or systemic inflammation [20] [21] [22] are from individuals with moderate to high CVD risk, 19, 22 diabetes mellitus, 18, 20 or ischemic heart disease. 21 As a result, it remains unclear whether endothelial dysfunction reflects direct PM 2.5 -induced injury or is secondary to disease exacerbation because of PM 2.5 inhalation. Because endothelial dysfunction and systemic inflammation are strongly associated with atherosclerosis 23, 24 and diabetes mellitus, 25, 26 an increase in the severity of these diseases would affect both the immune system and the endothelial function, even if these processes were not direct targets of PM 2.5 . Therefore, it is difficult to conclude that inhaling PM 2.5 leads to systemic inflammation or endothelial dysfunction or to determine how these changes may be related to the pathogenesis of atherosclerotic lesion formation and acute coronary events.
Hence, to determine whether PM 2.5 directly affects the endothelium, we examined biomarkers of subtle endothelial injury and mild systemic inflammation in a cohort of young healthy individuals with low CVD risk. It has been previously reported that the acute inhalation of PM 2.5 does not induce frank endothelial dysfunction in healthy individuals 18 ; therefore, to identify subclinical, endothelial injury, we measured circulating levels of endothelium-derived microparticles. Microparticles are submicron vesicular structures that are shed from activated or apoptotic cells. [27] [28] [29] Elevated circulating levels of such microparticles reflect endothelial damage. 30, 31 To evaluate systemic inflammatory responses, we measured changes in immune cells, cytokines, growth factors, and vascular adhesion molecules. We found robust evidence of endothelial injury and systemic inflammation with exposure to increased PM 2.5 levels even in young healthy individuals. These findings lend support to the view that PM 2.5 causes endothelial injury, potentially by establishing a mild inflammatory state. Our results are also consistent with the possibility that aberrant immune responses and endothelial injury may be early causes of endothelial dysfunction and CVD attributable to PM 2.5 exposure in susceptible individuals.
Methods

Study Population
Research subjects included 3 groups of 24 persons (Table 1) who were recruited for each of 3 consecutive winter/spring study periods, including January to March 2013, January to March 2014, and December 2014 to April 2015. All study participants were healthy, young adults recruited from Provo, UT. All subjects were nonsmokers without exposure to second-hand smoke at home, work, or school. Air pollution episodes in Utah Valley occur under predictable conditions that include a combination of snow cover, relatively high barometric pressure, and stagnant atmospheric conditions. For each of the study periods, subjects were further divided into 2 draw groups of 12. At prearranged times (between 11:00 am and 12:00 pm on Tuesdays or Thursdays) and during times of variable air pollution, the subjects in each draw group had their blood drawn (Figure 1) and completed a questionnaire about current health status, level of exercise, beginning date of the last menstrual period, and supplement use.
In the first study period, only males were enrolled, whereas in the other periods, both sexes were enrolled. For the second and third study periods, subjects were provided with dietary supplements and asked to consume 2 640 mg soft gel tablets in the morning and evening with food. Consumption of these supplements began 3 weeks before the first blood draw and continued until the final blood draw. Subjects were randomly (stratified by sex and group) assigned capsules of omega-3 fatty acids (a total daily consumption of 2560 mg, within the upper range of recommended dose) or identically sized placebo capsules of soybean oil (Pro Omega softgel/lemon capsules and Placebo Soybean Oil softgel/lemon, Nordic Naturals, Inc, Watsonville, CA). Informed consent was obtained from all research subjects. The study was approved by the Institutional Review Board for Human Subjects at Brigham Young University, and procedures followed were in accordance with institutional guidelines.
Blood Collection and Processing
For the analysis of microparticles and immune cell populations, 8 mL of blood was collected in sodium citrate-containing cell preparation tubes (CPT Vacutainer; Becton Dickinson). These tubes were centrifuged at 1700g for 30 minutes at room temperature and shipped overnight to the University of Louisville for analysis. On arrival, the tubes were centrifuged again, and the upper layer containing mononuclear cells and plasma was collected. This material was diluted with an equal volume of PBS and centrifuged at 500g for 10 minutes. Aliquots of the supernatant were used for the analysis of microparticles, whereas the cell pellet was washed once with PBS and centrifuged. For the analysis of platelet-monocyte aggregates, 3 mL of blood was collected in an acid-citrate dextrose tube (ACD Vacutainer; Becton-Dickinson), and then 1 mL of aliquots was diluted with 3 mL of PBS and fixed with 1.3 mL of 4% paraformaldehyde for 30 minutes on ice. Red blood cells were lysed by the addition of 24 mL of water, the samples centrifuged at 400g for 10 minutes, and the cell pellet resuspended in 1 mL of Tyrode buffer and shipped to the University of Louisville as above.
Inflammatory cytokines were measured in frozen plasma aliquots by analytic services at Eve Technologies (Calgary, Alberta, Canada). An array of 42 human cytokines (Human Cytokine Array/Chemokine Array 42-Plex, Discovery Assay) and an array that included soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vascular cellular adhesion molecule (sVCAM-1; Human Neurodegenerative Disease Array 2-Plex, Discovery Assay) were analyzed using multiplexing laser bead technology.
Flow Cytometry
To measure microparticles, plasma aliquots were centrifuged for 2 minutes at 10 000g to pellet residual cells and debris. The supernatant was collected and then centrifuged for 45 minutes at 17 000g. The resulting microparticle pellet was resuspended in PBS containing 1% FCS and 2.5 mmol/L Ca 2+ and incubated with Fc block for 10 minutes at 4°C. Then a cocktail of fluorescently conjugated antibodies including Pacific blue-Annexin V (Life Technologies), APC-anti-CD34 (Becton Dickinson), PECy7-anti-CD41 (Becton Dickinson), PE-anti-CD31 (eBioscience), PECy5.5-anti-CD62E (Becton Dickinson), FITC-anti-EphB4 (R&D Systems), and APC-anti CD143 (Biolegend) was added. In addition, 1 antibody (anti-Ephrin B2; Santa Cruz) was labeled in the laboratory (Zenon Alexa 488 labeling kit; Life Technologies) and also added to the staining cocktail. After 30 minutes at room temperature, 25 000 volumetric counting beads were added and 10 000 events were collected on a multilaser flow cytometer (Becton Dickinson, BD™ LSR II). An identical sample with no antibodies was used as a gating control. Microparticle numbers were quantified in gated populations <1 µm in size and positive for Annexin V staining using the FlowJo software package and normalized to the number of counting beads (volume) collected. Specific populations were defined by phenotype as documented in Table 2 and illustrated in Online Figure I.
To quantify immune cell populations, resuspended cell pellets from above were incubated with Fc block (Miltneyi) for 10 minutes at 4°C, followed by the addition of fluorescently tagged antibodies (eBioscience) recognizing CD14 (650NC), CD16 (fluorescein isothiocyanate [FITC]), CD19 (Alexa 700), CD8 (APC-e780), and CD4 (PECy7) for 30 minutes at 4°C. The cells were washed once, resuspended in 350 μL PBS+2% FCS and 50 000 volumetric counting beads (Accucount Particles; Spherotech) were added before analysis. Samples were collected for 2 minutes on the multilaser flow cytometer (Becton Dickinson). Cell numbers were quantified using the FlowJo software package and normalized to the number of counting beads (volume) collected.
To quantify platelet-monocyte aggregates, cell pellets from above were washed once in Tyrode solution and then incubated with Fc block (Miltenyi) for 10 minutes on ice. The samples were then incubated with an FITC-conjugated anti-CD41 antibody (eBioscience) and an APC-conjugated anti-CD45 (eBioscience) antibody for 30 minutes on ice, washed, resuspended in Tyrode solution, and 10 000 events were collected on the multilaser flow cytometer. A sample with isotype control antibodies was used as a control. The percent of double-positive events was determined using FloJo software.
Measurement of PM 2.5 Air Pollution
Daily ambient concentrations of PM 2.5 in Utah Valley were collected from 3 monitoring sites: Lindon (located at the northern part of the valley), North Provo (approximately centrally located), and Spanish Fork (located at southern end of valley). At the Lindon and North Provo sites, hourly concentrations of PM 2.5 , based on continuous ambient monitors, were also collected and used to estimate average PM 2.5 concentrations for the 24-hour period from noon to noon for each day-the approximate 24-hour time period before each blood draw. These data were obtained from the Utah Department of Environmental Quality (Salt Lake City, UT). During the past 2 study periods, supplemental continuous ambient monitoring of PM 2.5 (using a Thermo Scientific tapered element oscillating microbalance TEOM monitor) was conducted outside of the building, where the blood draws were conducted and indoor monitoring (using a Thermo Scientific portable DataRAM4 monitor) was conducted inside the blood-draw room. Average PM 2.5 concentrations for the 24-hour period from noon to noon for each day were calculated. Monitored PM 2.5 concentrations were nearly identical for all ambient monitors ( Figure 1 ). The indoor measured concentrations of PM 2.5 were much lower. PM 2.5 concentrations from the North Provo monitor were used as the primary exposure measure.
Statistical Analysis
Associations with PM 2.5 exposures and microparticles and markers of inflammation were evaluated by estimating 2 similar regression approaches: fixed-effects regression models controlling for subjectspecific differences and a subject-mean-adjusted regression that accounts for subject-specific differences by subtracting out subjectlevel means. The fixed-effects model controls for subject-level differences by estimating subject-specific fixed-effects as part of the model, whereas the subject-mean-adjusted model controls for subject-level differences by first subtracting out the subject-level means, and regressing deviations from these means on PM 2.5 (expanded statistical methods in the Online Data Supplement).
Plots of subject-specific differences over pollution concentrations along with regression plots were generated. To explore the sensitivity of the results, models were estimated that excluded observations from participants who reported any acute illness at the time of the blood draw, models that controlled for time exercised on the day of the draw and the day before the draw, models that controlled for menstruation (as indicated by blood-draw date being <6 days since beginning date of the last menstrual period), and models that excluded observations for days with PM 2.5 concentrations >100 µg/m 3 . In addition, rather than using PM 2.5 concentrations 24 hours before the blood draws, models that used PM 2.5 concentrations 12 and 48 hours before the blood draws, respectively, were estimated. Finally, using data for the final 2 winter/ spring time periods, models that included interaction terms for sex and PM 2.5 , and fish oil (versus placebo) and PM 2.5 were estimated to test for the effect modification by sex and by fish oil supplement use.
For analysis of the multiple inflammatory cytokines and adhesion molecules, we estimated the fixed-effects and subject-mean-adjusted models. The percent change (and 95% confidence intervals) for each analyte per 10 µg/m 3 increase in PM 2.5 relative to its mean value was calculated and plotted in order based on t values. This approach comprehensively evaluates all measured analytes, allows for direct comparisons and evaluation of the strength of the statistical associations, and mitigates concerns about multiple testing and selective reporting. All statistical analyses were conducted using SAS, version 9.4 (SAS Institute, Inc, Cary, NC).
Results
A summary of selected characteristics of research subjects is provided in Table 1 . PM 2.5 concentrations and timing of blood draws for the 3 study periods are illustrated in Figure 1 . Table 2 presents descriptions and summary statistics of microparticle and immune cell measurements and subject-meanadjusted regression results. Online Table I reports regression results for the fixed-effects and subject-mean regressions. Delayed shipment of blood because of weather, broken blood collection tubes during centrifugation, and instrument malfunction during analysis resulted in some missing data. PM 2.5 concentrations were significantly (P<0.001) associated with elevated endothelial microparticles and all endothelial subgroups (venous, arterial, lung, nonlung, lung arterial, and lung venous). The associations were significant even after using a Bonferroni correction for multiple testing (P<0.05/15). Microparticles derived from endothelial progenitor cells, platelets, and activated endothelial cells (CD62 + ) were not positively associated with PM 2.5 . PM 2.5 concentrations were also significantly associated with elevated immune cell levels, including monocytes, natural killer cells, helper T cells, and killer T cells. PM 2.5 concentrations were not associated with B cells, but were weakly associated with platelet-monocyte aggregates.
PM 2.5 , Microparticles, and Immune Cells
The associations between PM 2.5 and subject-mean-adjusted values for endothelial microparticles and monocytes are illustrated in Figure 2A and 2B. Associations for lung, nonlung, venous, lung venous, arterial, and lung arterial endothelial microparticles are similar to that illustrated in Figure 2A . Indeed, relative effects of PM 2.5 exposures were similar across all endothelial subgroups. Expressed as a percent increase relative to the mean level of microparticles, a 10 µg/m 3 increase in PM 2.5 was associated with a 15% increase in all endothelial microparticles and a 15%, 14%, 10%, 9%, 19% and 19% increase in lung, nonlung, arterial, lung arterial, venous, and lung venous endothelial microparticles, respectively. With regards to the immune cell responses, a 10 µg/m 3 increase in PM 2.5 was associated with a 4%, 4%, 3%, and 3% increase in the levels of monocytes, natural killer cells, helper T cells, and killer T cells, respectively. Figure 3 presents the estimated associations between PM 2.5 and all 42 measured growth factors and cytokines and 2 soluble adhesion molecules. The estimated associations are presented as percent change (and 95% confidence intervals) in each analyte per 10 µg/m 3 increase in PM 2.5 relative to the mean. Estimated associations are ordered from left to right based on t values. PM 2.5 was associated with changes in several circulating growth factors and cytokines involved in systemic inflammation, including tumor necrosis factor α (TNF-α), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1α (MIP-1α) and MIP-1β, interferon γinduced protein 10 (IP-10), and interleukin 8 (IL-8), IL-6, and IL-1β, as well as the soluble adhesion proteins sICAM-1 and sVCAM-1.
PM 2.5 , Inflammatory Cytokines, and Adhesion Molecules
For TNF-α, MCP-1, IL-8, MIP-1α, MIP-1β, and IP-10, the associations were highly statistically significant with a 10 µg/m 3 incremental increase in PM 2.5 associated with a 1.25 (SE=0.19, P<0.0001), 5.22 (SE=1.09, P<0.0001), 2.96 (SE=0.70, P<0.0001), 0.86 (SE=0.21, P<0.0001), 1.65 (SE=0.52, P=0.002), and 4.05 (SE=1.34, P=0.003) pg/mL increase in each cytokine, respectively. The associations with TNF-α, MCP-1, IL-8, MIP-1α, and sICAM-1 were statistically significant even when using the Bonferroni correction for multiple testing of 44 analytes (P<0.05/44). For IL-6, IL-10, and IL-1β, the associations were also observed, but they were marginally statistically significant with a 10 µg/m 3 increase in PM 2.5 associated with a 0.09 (SE=0.05, P=0.05), 0.11 (SE=0.06, P=0.05), and 0.29 (SE=0.15, P=0.06) pg/mL increase in each cytokine, respectively. Elevated PM 2.5 exposures were associated with significant reductions in the epidermal growth factor (EGF) and platelet-derived growth factor, as well as sCD40L (soluble CD40 ligand), growth-regulated protein α (GROα), and RANTES (regulated on activation, normal T-cell-expressed and secreted; Figure 3 ). Elevated PM 2.5 exposures were also significantly associated with the 2 soluble adhesion molecules, sICAM-1 and sVCAM-1, with a 10 µg/m 3 increase in PM 2.5 associated with a 628.43 (SE=125.19, P<0.0001) and 2288.44 (SE=1030.08, P=0.03) pg/mL increase, respectively. The associations between subject-mean-adjusted values for TNF-α and sICAM-1 Figure 2C and 2D. Highly significant positive associations are observed, but this illustration also demonstrates that most of the variability remains unexplained by PM 2.5 .
Table 2. Description and Summary Statistics of Microparticles and Immune Cells and Regression Coefficients for PM 2.5 From the Subject Mean-Adjusted Regression Models
Sensitivity Analysis
Overall, the results were not highly sensitive to alternative modeling choices. Similar results were obtained for the fixedeffects and subject-mean-adjusted regression models, as well as models that treated all out-of-range cytokine/growth factor observations as missing observations (Online Tables I, II, and  III) . Also, similar results were obtained from models excluding draws from participants who reported illness, models controlling for concurrent and previous days' time exercising, models controlling for menstruation, models that exclude days with PM 2.5 concentrations >100 µg/m 3 , and models that used PM 2.5 concentrations 12 and 48 hours before blood draws (rather than 24 hours). A formal comparison of effect estimates for these regression models for selected variables is presented in Online Figure II . Furthermore, for the final 2 study periods, models that included sex and PM 2.5 and fish oil (versus placebo) and PM 2.5, interaction terms were estimated to test for effect modification. Overall, there was no consistent evidence of effect modification by either sex or use of fish oil supplements.
Discussion
The major findings of this study, as stylistically illustrated in Figure 4 , are that episodic exposure to PM 2.5 was associated with an increase in circulating microparticles indicative of endothelial apoptosis, and an inflammatory, antiangiogenic blood profile associated with selective increases in T, rather than B, lymphocytes. Taken together, these findings reveal a characteristic signature of systemic injury inflicted by PM 2.5 exposure and could provide new insights into potential mechanisms by which inhalation of PM 2.5 increases CVD risk and severity, leading to premature cardiovascular mortality. Because plasmatic changes were observed in a young, healthy population with low CVD risk burden, these findings suggest that even in the absence of pre-existing disease, and unconfounded by significant disease progression, inhalation of PM 2.5 induces endothelial injury and inflammation. Therefore, these changes are likely to be early signs of systemic injury, which if sustained, could contribute to the development or exacerbation of atherosclerotic disease and the precipitation of acute cardiovascular events in susceptible individuals.
Although previous epidemiological evidence suggests that exposure to PM 2.5 contributes to the development of CVD, [1] [2] [3] [4] [5] [6] 9, 12, [14] [15] [16] the mechanistic basis of this injury is not fully understood. One potential pathway is the release of proinflammatory mediators by alveolar macrophages or epithelial cells on exposure to airborne particles. Indeed, exposure to concentrated PM results in the release of proinflammatory cytokines, such as IL-6 or TNF-α from alveolar 32 or peritoneal 33 macrophages. Similarly, human airway cells 34 or bronchial epithelial cells 35 release TNF-α, IL-6, or IL-8 on incubation of ambient air particles. Our observation showing that circulating levels of TNF-α, IL-8, and IL-6 are increased on PM 2.5 inhalation is consistent with the possibility that the release of cytokines in the lung could trigger and sustain a state of mild systemic inflammation.
Systemic inflammation due to PM 2.5 inhalation could by itself contribute to both an increase in the thrombotic propensity of the blood and proatherogenic changes in the vessel wall. Our observation of an association between increased plateletmonocyte aggregate levels in the peripheral blood and PM 2.5 exposure ( Table 2) suggests that PM 2.5 exposure does indeed establish an early procoagulation state, even in healthy adults, which might be an important contributor to CVD risk associated with PM 2.5 exposure. Although in humans it is difficult to directly measure proatherogenic changes in the vessel wall and atherosclerotic disease progression in young healthy humans, we did find clear signs of endothelial injury, reflected by an increase in the circulating levels of endothelial microparticles, derived mostly from the venous endothelium. Notably, this location is just upstream of the coronary circulation putting these particles potentially at higher levels near susceptible coronary artery plaques in high-risk individuals. Thus, the increased levels of endothelial microparticles in disease-free individuals are likely suggestive of injury that precedes the development of frank disease. Nonetheless, the mechanisms by which PM 2.5 triggers the release of microparticles from the lung remain unclear. Exposure to inflammatory cytokines such as TNF-α could stimulate the release of microparticles by activating the endothelium, 36 and increased levels of activated (CD62 + ) endothelial microparticles are associated with the states of high inflammation that accompany acute cardiovascular events. 37 However, we found no association between CD62 + microparticles and PM 2.5 exposure, suggesting that most endothelial microparticles released on exposure to PM 2.5 are derived from apoptosis, not cytokine-induced activation, of the endothelium. A similar increase in the plasma levels of apoptotic, not activated, endothelial ACE + microparticles has been observed also in smokers with normal spirometry, 38 suggesting that pathological changes associated with smoking and PM 2.5 exposure share overlapping mechanisms that involve early lung destruction, followed by subsequent cardiovascular injury.
Although elevated levels of specific cytokines such as TNF-α cannot be linked to the generation of activated endothelial microparticles, the collective pattern of changes in plasma cytokines is indicative of an antiangiogenic state. All the cytokines and growth factors that were suppressed with PM 2.5 exposure-EGF, CD40L, platelet-derived growth factor-AA, GROα, RANTES, and vascular endothelial growth factor (VEGF)-have a key property in common. They are all potent angiogenic factors. The growth factor VEGF is required for in vivo angiogenesis and the growth of macrovascular endothelial cells, 39 whereas EGF increases the growth and proliferation of microvascular endothelial cells, particularly in the presence of platelet-derived growth factor. 40, 41 EGF is also a strong trophic factor that prevents endothelial cells against TNF-α-induced apoptosis, 42 and the blockage of EGFR signaling in vivo induces endothelial apoptosis. 43 RANTES is also a proangiogenic factor. It promotes endothelial cell migration, spreading and neovessel formation, and RANTES-mediated angiogenesis depends at least partly on VEGF. 44, 45 The chemokine, GROα is essential for thrombin-induced angiogenesis and it increases VEGF production by endothelial cells. 46 Downregulation or inhibition of GROα markedly decreases VEGF expression by guest on November 30, 2016 http://circres.ahajournals.org/ Downloaded from and the angiogenic potential of endothelial cells. 47 Likewise, the interaction of sCD40L with CD40 on endothelial cells has been shown to increase the expression of VEGF and stimulate angiogenesis. 48, 49 Overall, the association of PM 2.5 with lower circulating levels of sCD40L, EGF, platelet-derived growth factor, GROα, RANTES, and VEGF suggests that the loss of trophic, angiogenic factors could account for the increase in apoptosis of endothelial cells on PM 2.5 exposure.
The antiangiogenic state established by the loss of angiogenic growth factors seems to be further exacerbated and reinforced by a corresponding increase in antiangiogenic cytokines, such as TNF-α and IP-10. IP-10 is secreted by activated T cells, monocytes and endothelial cells, and elevated levels of this cytokine has been linked to inflammatory disorders, such as asthma. 50 It inhibits the development of new vasculature and causes the regression of newly formed vessels 51 and is strongly induced on the stimulation of monocytes with TNF-α. 52 Elevation in the circulating levels of TNF-α and other cytokines such as MCP-1, IL-8, and MIP-1α/MIP-1β are indicative of a proinflammatory state associated with increased chemotaxis and atherogenesis. High circulating levels of MCP-1 53 and IL-8 54 are associated with increased risk of all-cause mortality in patients with CVD. Interestingly, circulating levels of MIP-1β and TNF-α correlate significantly with plaque levels of these cytokines, 55 suggesting that PM 2.5 associated increases in the plasma levels of these cytokines may be reflective of increased vascular inflammation.
The pattern of changes in plasma cytokine levels associated with PM 2.5 exposure may also be linked with the observed increases in circulating lymphocytes. Cytokines such as MCP-1 56 and IP-10 57 exert potent chemotactic activity toward monocytes and T lymphocytes, whereas IL-9 stimulates the . Schematic representation of the proposed mechanism by which fine particulate matter <2.5 µm in aerodynamic diameter (PM 2.5 ) induces vascular injury. Inhalation and deposition of PM 2.5 in the lungs triggers inflammatory responses that lead to the release of inflammatory cytokines (tumor necrosis factor α [TNF-α], monocyte chemoattractant protein 1, and interleukin 8), the recruitment of immune cells (CD14 + monocytes, CD16 + natural killer cells, and CD4 + and CD8 + T cells), suppression of growth/ angiogenic factors (epidermal growth factor, CD40L, platelet-derived growth factor-AA, regulated on activation, normal T cell expressed and secreted, and growth-regulated protein α), and an increase in anti-angiogenic factors (TNF-α and interferon γ-induced protein 10), resulting in endothelial cell apoptosis and the generation of endothelial microparticles in blood. These events are associated with an increase in circulating levels of soluble adhesion molecules (sICAM-1 [soluble intercellular adhesion molecule 1] and sVCAM-1 [soluble vascular cellular adhesion molecule 1]) and platelet-monocyte aggregates. Collectively, these responses contribute to the pathogenic sequelae of atherogenesis and may increase thrombotic potential increasing risk of acute cardiovascular events.
by guest on November 30, 2016 http://circres.ahajournals.org/ Downloaded from proliferation of activated T cells. Hence, an increase in these cytokines may be linked to the increased levels of monocytes and T cells. Notably, no change in the levels of B cells was observed, suggesting a lack of an adaptive immune response. Because PM 2.5 lacks proteins or other T-cell-dependent antigens, as well as non-T-cell-dependent antigens such as foreign polysaccharides or DNA, it may be insufficient to induce a humoral response. Nevertheless, selective increase in T, but not B, cell populations may be indicative of increased cytokine production and the formation of autoantigens generated by injured or dying endothelial cells.
Previous studies have shown that PM 2.5 exposure of just a few hours or days is associated with both fatal and nonfatal ischemic stroke and acute coronary syndrome events. [12] [13] [14] [15] [16] This evidence suggests that there are systemic responses to even short-term PM 2.5 exposure that play a role in triggering acute cardiovascular events. 1 Our observation that episodic increases in PM 2.5 are associated with an increase in endothelial microparticles, lymphocytes, and cytokines suggests a potential mechanism for the acute effects of PM 2.5 . Although cause-and-effect relationships are not easily disentangled, our results are consistent with a scenario in which the inhalation of PM 2.5 triggers proinflammatory and antiangiogenic cytokine profile, which in turn induces endothelial cell apoptosis, leading to the increased levels of circulating microparticles. These microparticles carry metalloproteases, 58 which can induce endothelial cell apoptosis 28 or contribute to the disruption or erosion of unstable plaques in susceptible individuals. Notably, metalloproteases are responsible for the cleavage and generation of soluble adhesion molecules, including sICAM-1 and sVCAM-1 from the endothelium, both of which were increased in association with PM 2.5 exposure. Thus, an increase in microparticles on PM 2.5 exposure could disseminate proinflammatory mediators and spread inflammation beyond the lung to establish and sustain low-grade inflammation and aggravate the atherothrombotic process. 29 The characteristic pattern of changes in cytokines, chemokines, endothelial microparticles, and blood lymphocytes reported here may be diagnostic of exposure to PM 2.5 and may be useful in distinguishing PM 2.5 -induced injury from that induced by the inhalation of other toxins, such as tobacco smoke. Although direct comparisons are not yet available, the pattern of changes we observed on exposure to PM 2.5 seems to differ from that observed with smoking. Although like PM 2.5 exposure, smoking is also associated with endothelial apoptosis and a decrease in the plasma levels of CD40L, 59 EGF, 60 and GROα, 61 it is generally associated with the increased blood levels of VEGF, 62 which is due to the stimulatory effect of nicotine on VEGF 63 or due to hypoxia induced by CO in cigarette smoke. Also, unlike PM 2.5 exposure, smoking is not usually associated with an increase in plasma TNF-α or MCP-1 levels. 64 Hence, although further research is clearly needed, direct future comparisons between the pattern of changes with PM 2.5 and other inhaled toxic substances may help discern, and thereby more reliably attribute, cardiovascular injury due to PM 2.5 exposure.
Strengths of this study are its size and design. The number of available observations during the 3-year period, multiple observations per subject, and the ability to control for subject-specific differences using fixed-effects models or models using subject-mean-adjusted variables provided adequate power to test the primary hypotheses. This approach allows for matching and control for subject-specific differences, such as age, sex, race, genetics, health, etc. In this study, there was minimal potential for confounding by active smoking or exposure to second-hand cigarette smoke. Another primary strength of our study is that we evaluated PM 2.5 associations under real-world conditions with relevant exposures. Despite these strengths, the study also has limitations. Although pollution episodes were predictable, we could only control the timing of the blood draws. We were generally successful at getting observations during pollution episodes but, in the third-year study period, no substantive pollution episode occurred.
In conclusion, episodic PM 2.5 air pollution exposures were associated with the increased levels of endothelial microparticles and systemic increase in antiangiogenic cytokines and a suppression of angiogenic growth factors in young healthy adults. The effects are statistically significant, and the pattern of results is coherent and consistent. Although these findings need validation with additional research, they suggest that the inhalation of PM 2.5 can instigate adverse cardiovascular responses through changes in cytokine and growth factor levels, leading to endothelial injury and increased abundance of monocytes and T cells in the peripheral blood; responses that could potentially initiate and promote atherosclerotic lesions and trigger acute cardiovascular and cerebrovascular events. Nevertheless, we found that air pollution exposure explained only a small amount of the variability in endothelial microparticles and markers of inflammation, suggesting that exposure to air pollution is one of multiple factors that influences cardiovascular health.
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• Exposure to fine particulate air pollution (PM 2.5 ) is associated with increased risk of cardiovascular disease and mortality and contributes substantially to global burden of disease. • Although PM 2.5 -induced systemic inflammation and endothelial dysfunction have been implicated, it remains unclear how inhaled PM 2.5 , a pulmonary insult, can induce cardiovascular injury and exacerbate cardiovascular disease.
What New Information Does This Article Contribute?
• In healthy, nonsmoking, young adults, episodic exposure to PM 2.5 was associated with elevated circulating endothelial microparticles, indicative of endothelial cell apoptosis and endothelial injury. • PM 2.5 exposure was associated with inflammatory responses, including an increase in immune cells, a systemic increase in antiangiogenic cytokines, and a suppression of proangiogenic growth factors. • Circulating levels of soluble adhesion molecules and platelet-monocyte aggregates were also elevated with PM 2.5 exposure.
Extensive epidemiological evidence indicates that exposure to ambient PM 2.5 contributes to cardiovascular disease and mortality, but it is unclear how exposure to PM 2.5 causes cardiovascular injury. We collected blood from panels of healthy, nonsmoking young adults who were environmentally exposed to episodes of elevated PM 2.5 levels. Exposure to this pollution was positively associated with markers of endothelial injury and systemic inflammation. The evidence suggests that inhalation and pulmonary deposition of PM 2.5 triggers inflammatory responses characterized by an increase in antiangiogenic cytokines and suppression of proangiogenic growth factors, which could result in increased endothelial cell death and the generation of endothelial microparticles. In combination with observed elevated levels of soluble adhesion molecules and platelet-monocyte aggregates, these responses could contribute to atherogenesis, and thrombosis, and thereby increase the risk of acute cardiovascular events.
SUPPLEMENTAL MATERIAL
EXPANDED STATISITCAL METHODS
Associations with PM 2.5 exposures and microparticles and markers of inflammation were evaluated by estimating two similar regression models. The first model used a fixed effects regression approach that controls for subject-specific differences by estimating a fixed effects model as follows:
where Y it is the outcome variable for individual i on day t; α 1 + α 2 + . . . + α 72 are the fixed effects coefficients that adjust for subject-specific differences; β is the coefficient that measures the association between PM 2.5 and the outcome variable, P t is PM 2.5 averaged over the 24 h period prior to the blood draw on day t; and ε it is the model error. The second model uses a subject-mean adjusted approach that accounts for subject-specific differences by subtracting out subject-level means as follows:
where i is the mean value for individual i. The difference between the two models is that the fixed effects model controls for subject-level differences by estimating subject-specific fixed effects as part of the model. The subject-mean adjusted model controls for subject-level differences by first subtracting out the subject-level means, and regressing deviations from these means (ΔY it ) on PM 2.5 .
To illustrate associations, plots of the subject-specific differences over pollution concentrations along with regression plots were generated. To explore the sensitivity of the results, models were estimated that excluded observations from any participant who reported any acute illness at time of the blood draw, models that controlled for time exercised on the day of the draw and the day before the draw, models that controlled for whether or not female subjects were menstruating, and models that excluded observations for days with PM 2.5 concentrations greater than 100 µg/m 3 . Additionally, rather than using PM 2.5 concentrations 24 h prior to the blood draws, models that used PM 2.5 concentrations 12 h and 48 h, respectively, were estimated. Finally, using data for the final two winter/spring time periods, models that included interaction terms for gender and PM 2.5 , and fish oil (versus placebo) and PM 2.5 were estimated to test for effect modification by gender and by fish oil supplement use.
For the 42 analyzed human cytokines and the 2 adhesion proteins, we also estimated the fixed effects and subject-means adjusted models as described above. The percent change (and 95% Cis) for each analyte per 10 µg/m 3 increase in PM 2.5 relative to the mean value of the analyte were calculated and plotted. The results are ordered based on t-values-resulting in the most statistically significant positive associations being on the left. This approach was used in order comprehensively evaluate all of the measures analytes, allow for direct comparisons and evaluation of the strength of the statistical associations with key markers of systemic inflammation, and to mitigate concerns regarding multiple testing and selective reporting.
All of the statistical analyses were conducted using SAS, version 9.4 (SAS Institute, Inc., Cary, North Carolina). , and sICAM-1 (Panel C) using various regression models. These models include: fixed-effects and subject-mean adjusted models with all observations; subject-mean adjusted models excluding draws from participants who reported illness; models controlling for concurrent and previous days' time exercising; models controlling for menstruation; models that exclude days with PM 2.5 concentrations greater than 100 µg/m 3 ; and models that used PM 2.5 concentrations 12 h and 48 h prior to blood draws (rather than 24 h).
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